R
Roger Stupp
Researcher at Northwestern University
Publications - 463
Citations - 73077
Roger Stupp is an academic researcher from Northwestern University. The author has contributed to research in topics: Temozolomide & Glioma. The author has an hindex of 93, co-authored 430 publications receiving 63025 citations. Previous affiliations of Roger Stupp include Merck & Co. & University of St. Gallen.
Papers
More filters
Journal ArticleDOI
Predicting survival using health related quality of life scores in glioblastoma cancers: Findings from an international phase III randomised controlled trial
A. Bottomley,Martin J B Taphoorn,C. Coens,David Osoba,Kristel Van Steen,F. Efficace,M. J. van den Bent,B. Baumert,Warren P. Mason,Roger Stupp +9 more
TL;DR: In this paper, the prognostic value for survival of baseline health-related quality of life (HRQOL) parameters in glioblastoma multiforme (GBM) patients was explored.
Journal ArticleDOI
Preoperative chemoradiotherapy with cisplatin and docetaxel for stage IIIB non-small-cell lung cancer: 10-year follow-up of the SAKK 16/01 trial
M. Früh,Hans-Beat Ris,A. Xyrafas,S. Peters,René-Olivier Mirimanoff,O. Gautschi,Miklos Pless,Miklos Pless,Roger Stupp +8 more
TL;DR: It is demonstrated that selected patients can be cured by such an intensive treatment, and extended follow-up beyond 5 years, including chest imaging and optimal control of cardiovascular risk factors should be integrated in future clinical trials.
Journal ArticleDOI
Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels.
Andreas F. Hottinger,D. Bensaid,R. De Micheli,Bianca Moura,Karima Mokhtari,E. Cardoso,Ahmed Idbaih,Roger Stupp +7 more
Journal ArticleDOI
Atct-35quality of life, cognitive function and functional status in the ef-14 trial: a prospective, multi-center trial of ttfields with temozolomide compared to temozolomide alone in patients with newly diagnosed gbm
Jay-Jiguang Zhu,Susan C. Pannullo,Maximilian Mehdorn,F. Payer,Nicholas Avgeropoulos,Andrea Salmaggi,Antonio Silvani,Alessandro Olivi,Samuel Goldlust,Carlos A. David,Alexandra Benouaich-Amiel,Eilon D. Kirson,Zvi Ram,Roger Stupp +13 more
TL;DR: Quality of life was not adversely affected by the continuous use of TTFields and may be improved in some domains of the EORTC QLQ C-30 and BN20 and Cognitive and functional capabilities were not impeded by the addition of T TFields to TMZ therapy.
Journal ArticleDOI
18F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer
Igor Letovanec,Gilles Allenbach,A. Mihaescu,M. Nicod Lalonde,Sabine Schmidt,Roger Stupp,Jean-William Fitting,Ariane Boubaker,Hans-Beat Ris,John O. Prior +9 more
TL;DR: PET/CT may help to differentiate the malignant or benign origin of a pleural effusion with a high specificity in patients with known cancer, in particular NSCLC.